GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » Cyclically Adjusted PB Ratio

Mendus AB (OSTO:IMMU) Cyclically Adjusted PB Ratio : 0.09 (As of Jun. 03, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mendus AB Cyclically Adjusted PB Ratio?

As of today (2025-06-03), Mendus AB's current share price is kr5.10. Mendus AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr57.41. Mendus AB's Cyclically Adjusted PB Ratio for today is 0.09.

The historical rank and industry rank for Mendus AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:IMMU' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.15   Max: 0.88
Current: 0.09

During the past years, Mendus AB's highest Cyclically Adjusted PB Ratio was 0.88. The lowest was 0.07. And the median was 0.15.

OSTO:IMMU's Cyclically Adjusted PB Ratio is ranked better than
89.14% of 672 companies
in the Biotechnology industry
Industry Median: 1.475 vs OSTO:IMMU: 0.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Mendus AB's adjusted book value per share data for the three months ended in Mar. 2025 was kr12.203. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr57.41 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mendus AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Mendus AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Cyclically Adjusted PB Ratio Chart

Mendus AB Annual Data
Trend Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.49 0.69 0.16 0.13

Mendus AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.14 0.13 0.13 0.11

Competitive Comparison of Mendus AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Mendus AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mendus AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mendus AB's Cyclically Adjusted PB Ratio falls into.


;
;

Mendus AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mendus AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.10/57.41
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mendus AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Mendus AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=12.203/132.8245*132.8245
=12.203

Current CPI (Mar. 2025) = 132.8245.

Mendus AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 53.367 99.995 70.888
201509 46.912 100.228 62.169
201512 37.434 100.276 49.585
201603 32.074 100.751 42.284
201606 91.929 101.019 120.872
201609 84.013 101.138 110.335
201612 67.626 102.022 88.044
201703 53.994 102.022 70.296
201706 41.303 102.752 53.391
201709 26.997 103.279 34.720
201712 125.202 103.793 160.222
201803 58.025 103.962 74.134
201806 51.040 104.875 64.643
201809 42.552 105.679 53.482
201812 -6.670 105.912 -8.365
201903 75.260 105.886 94.407
201906 68.777 106.742 85.583
201909 62.858 107.214 77.873
201912 -1.134 107.766 -1.398
202003 48.137 106.563 60.000
202006 42.861 107.498 52.959
202009 38.419 107.635 47.410
202012 73.292 108.296 89.893
202103 68.636 108.360 84.132
202106 66.158 108.928 80.672
202109 63.654 110.338 76.626
202112 60.675 112.486 71.646
202203 58.135 114.825 67.248
202206 55.464 118.384 62.230
202209 51.843 122.296 56.306
202212 47.528 126.365 49.957
202303 44.637 127.042 46.669
202306 44.094 129.407 45.259
202309 17.405 130.224 17.753
202312 16.329 131.912 16.442
202403 15.574 132.205 15.647
202406 13.868 132.716 13.879
202409 13.417 132.304 13.470
202412 12.811 132.987 12.795
202503 12.203 132.825 12.203

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mendus AB  (OSTO:IMMU) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mendus AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Mendus AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mendus AB Business Description

Industry
Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals. Company Pipeline includes: Vididencel, Ilixadencel, Preclinical.

Mendus AB Headlines

From GuruFocus